TFPI2 and non-small cell lung carcinoma: Whether or not these mechanisms are also regulated within the lung by TFPI-2 has to be evaluated, but our findings strongly suggest that low expression of the TFPI-2 gene by tumour or stroma cells could also favour the development of NSCLC and metastases in vivo.